M&A Deal Summary |
|
---|---|
Date | 2008-09-25 |
Target | Medtronic CryoCath |
Sector | Healthcare Services |
Buyer(s) | Medtronic |
Deal Type | Add-on Acquisition |
Deal Value | 380M USD |
Advisor(s) | Davies Ward Phillips & Vineberg (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1949 |
Sector | Medical Products |
Employees | 95,000 |
Revenue | 32.4B USD (2024) |
Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.
DEAL STATS | # |
---|---|
Overall | 18 of 59 |
Sector (Healthcare Services) | 1 of 4 |
Type (Add-on Acquisition) | 18 of 57 |
State (Quebec) | 1 of 1 |
Country (Canada) | 1 of 2 |
Year (2008) | 2 of 2 |
Size (of disclosed) | 13 of 36 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-04-22 |
Restore Medical
St. Paul, Minnesota, United States Restore Medical, Inc. is a developer, manufacturer and marketer of innovative medical devices to treat sleep-disordered breathing. |
Buy | $29M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-01-12 |
Ablation Frontiers
Carlsbad, California, United States Ablation Frontiers, Inc.,a medical device company based in Carlsbad, Calif., dedicated to helping individuals suffering from AF and other cardiac arrhythmias. In 2006, Ablation Frontiers received CE Mark to begin marketing its system of catheters and the GENius™ Radiofrequency (RF) Generator in the European Union to treat supraventricular arrhythmias and for use in atrioventricular node ablation. |
Buy | $225M |